Inactive Instrument

Analyst Reco. Neothetics Inc Nasdaq

Equities

Laidlaw Downgrades Evofem Biosciences to Hold From Buy	Dec. 13	MT
Stifel Downgrades Evofem Biosciences to Hold From Buy, Adjusts Price Target to $0.50 From $3	22-10-13	MT
HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $2, Reiterates Buy Rating	22-08-15	MT
Morgan Stanley Adjusts Price Target for Evofem Biosciences to $0.75 From $2, Maintains Underweight Rating	22-07-14	MT
Laidlaw & Co. Initiates Evofem Biosciences at Buy with $3.50 Price Target	22-06-02	MT
Piper Sandler Adjusts Price Target on Evofem Biosciences to $2 From $30, Reiterates Overweight Rating	22-05-25	MT
Wall Street Set for Gains as China Rate Cut Boosts Sentiment	22-05-20	MT
Morgan Stanley Lowers Evofem Biosciences Price Target to $2 From $8.55, Maintains Underweight Rating	22-05-11	MT
EVOFEM BIOSCIENCES : HC Wainwright Adjusts Evofem Biosciences' Price Target to $2.50 from $4, Keeps Buy Rating	21-10-21	MT
EVOFEM BIOSCIENCES : Morgan Stanley Downgrades Evofem Biosciences to Underweight Rating From Equal-Weight, Lowers PT to $0.80 From $1	21-10-14	MT
EVOFEM BIOSCIENCES : Morgan Stanley Adjusts Price Target on Evofem Biosciences to $1 From $3, Maintains Equal-Weight Rating	21-08-12	MT
EVOFEM BIOSCIENCES : HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $7, Maintains Buy Rating	21-06-07	MT

No results for this search